Clarithromycin and Phenobarbital interaction

Clarithromycin and Phenobarbital: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Phenobarbital (SEZABY) label · effective 2025-12-23

Major

Drugs that Prolong the QT Interval : Avoid concomitant use.

Drug interactionsby drug classView label on DailyMed
Moderate

QT Prolongation SEZABY may prolong the QT interval [see Clinical Pharmacology (12.2)] .

Warnings and precautionsby drug classView label on DailyMed
Moderate

Drugs that Prolong QT Interval SEZABY may prolong the QT interval [see Warnings and Precautions (5.10) and Clinical Pharmacology (12.2)] .

Drug interactionsby drug classView label on DailyMed
Moderate

Other products that may also prolong the QTc interval may have additive effects, and products that may increase concentrations of phenobarbital [see Drug Interactions (7.1)] may increase the QT prolongation risk; therefore, avoid concomitant use of SEZABY and these products.

Drug interactionsby drug classView label on DailyMed

From the Clarithromycin label · effective 2026-01-01

Moderate

John’s Wort Use With Caution There have been spontaneous or published reports of CYP3A based interactions of clarithromycin with alfentanil, methylprednisolone, cilostazol, bromocriptine, vinblastine, phenobarbital, and St.

Drug interactionsnames PhenobarbitalView label on DailyMed
Moderate

Antiepileptics: Carbamazepine Use With Caution Carbamazepine: Concomitant administration of single doses of clarithromycin and carbamazepine has been shown to result in increased plasma concentrations of carbamazepine.

Drug interactionsby drug classView label on DailyMed
Moderate

Miscellaneous Cytochrome P450 Inducers: Efavirenz Nevirapine Rifampicin Rifabutin Rifapentine Use With Caution Inducers of CYP3A enzymes, such as efavirenz, nevirapine, rifampicin, rifabutin, and rifapentine will increase the metabolism of clarithromycin, thus decreasing plasma concentrations of clarithromycin, while increasing those of 14-OH-clarithromycin.

Drug interactionsby drug classView label on DailyMed
Moderate

Alternative antibacterial treatment should be considered when treating patients receiving inducers of CYP3A.

Drug interactionsby drug classView label on DailyMed
Minor

Other Drugs Metabolized by CYP3A: Alfentanil Bromocriptine Cilostazol Methylprednisolone Vinblastine Phenobarbital St.

Drug interactionsnames PhenobarbitalView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.